Birmingham scientists have identified essential genetic code for a method called plasmid curing, which aims to ‘displace’ antibiotic resistance genes from bacteria.
Plasmids, which are small, circular strands of DNA, play a crucial role in allowing bacteria to share beneficial genes rapidly in a changing environment, most concerningly when they carry genes conferring resistance to antibiotics.
Professor Chris Thomas from Birmingham’s School of Biosciences has investigated plasmid curing for many years, and engineered useful “multi-copy” (many copies in each bacterium) plasmids for this purpose, resulting in a patented, efficient way to displace unwanted plasmids that carry resistance.
However, when developing this into a “pro-biotic” system that could spread through the gut on “low-copy” plasmids, the Thomas lab found that they had to engineer the plasmid to have a higher number of copies before it gave efficient displacement, which they called “potentiation”. 1
His further work, published in Nucleic Acids Research , explored why this potentiation was necessary and discovered that the issue lay in part of the “problem” F plasmids that are often found in E. coli bacteria and which his lab was using as their model target system.
Professor Thomas said: “We have identified the part of the plasmid that is absolutely essential for it to work in plasmid displacement, and built a completely new ‘curing cassette’ that does not need to be potentiated.”
While the current paper covers the basic science and reveals the genetic code that underpins this more robust design, Professor Thomas’ work has now moved on to investigating the spread of plasmids in animal models of the gut. The paper describing the results of this further work is in preparation and he says it is very encouraging.
“We know that animals are reservoirs of antibiotic resistance genes that can be transmitted to humans, and we now understand better how to make curing plasmids that work in a real context.”
Professor Thomas, and his research collaborators at Harper Adams University, Surrey University Veterinary School, and the Animal and Plant Health Agency, are now seeking commercial partners interested in developing ingestible probiotics to combat antibiotic resistance in gut bacteria, in both animals and humans.
Nucleic Acids Research
Experimental study
Cells
Activation, incompatibility, and displacement of FIB replicons in E. coli
10-Apr-2025
C.M.T. is Director of the company Plasgene that develops and sells plasmid displacement technology. We do not believe this is a problem because this manuscript is focused on explaining a limitation on the use of certain plasmid displacement tools (curing plasmids). It also reveals fundamental properties of a specific replicon type (FIB) which add significantly to the field of plasmid biology. It does not promote a specific product but it provides general advice about design features which could be used by anyone who has read the paper.